Therapeutic applications of lipoic acid: A patent review (2011-2014)

Expert Opinion on Therapeutic Patents

Volumn 24, Issue 9, 2014, Pages 993-1005

  Koufaki, Maria ^a  

^a INSTITUTE OF BIOLOGY   (Greece)

Author keywords

Cancer; Diabetes; Inflammation; Lipoic acid; Lipoic acid conjugates; Neurodegenerative diseases; Nutraceuticals; Pain

Indexed keywords

ANTIINFLAMMATORY AGENT; COSMETIC; DIHYDROLIPOATE; THIOCTIC ACID;

CHEMICAL STRUCTURE; CLINICAL TRIAL (TOPIC); CONJUGATE; DIABETIC NEUROPATHY; DRUG BIOAVAILABILITY; DRUG METABOLISM; HUMAN; NEUROPROTECTION; NONHUMAN; PATENT; PHARMACOPHORE; PUBLICATION; REVIEW; ANIMAL; BIOAVAILABILITY; CHEMISTRY; DIABETIC NEUROPATHIES; DIET SUPPLEMENTATION; DRUG DESIGN; DRUG STABILITY; MEDICINAL CHEMISTRY;

ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DIABETIC NEUROPATHIES; DIETARY SUPPLEMENTS; DRUG DESIGN; DRUG STABILITY; HUMANS; PATENTS AS TOPIC; THIOCTIC ACID;

EID: 84906214385     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2014.937425     Document Type: Review

References (102)

1. Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 1995;19:227-50
2. Biewenga GP, Haenen GRM, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997;29:315-31
3. Moini H, Packer L, Saris N-E L. Antioxidant and prooxidant activities of R-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol 2002;182:84-90
4. Navari-Izzo F, Quartacci MF, Sgherri C. Lipoic acid: a unique antioxidant in the detoxification of activated oxygen species. Plant Physiol Biochem 2002;40:463-70
5. Bast A, Haenen GRM. Lipoic acid: a multifunctional antioxidant. Biofactors 2003;17:207-13
6. Petersen Shay K, Moreau RF, Smith EJ, Hagen TM. Is alpha-lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity. Life 2008;60:362-7
7. Packer L, Cadenas E. Lipoic acid: energy metabolism and redox regulation of transcription and cell signalling. J Clin Biochem Nutr 2011;48:26-32
8. Kamenova P. Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid. Hormones 2006;5:251-8
9. Holmquist L, Stuchbury G, Berbaum K, et al. Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Pharmacol Ther 2007;113:154-64
10. Chaudhary P, Marracci G, Yu X, et al. Lipoic acid decreases inflammation and confers neuroprotection in experimental autoimmune optic neuritis. J Neuroimmunol 2011 233:90-6
11. Harding SV, Rideout TC, Jones PJH. Evidence for using alpha-lipoic acid in reducing lipoprotein and inflammatory related atherosclerotic risk. J Diet Suppl 2012;9(2):116-27
12. Castro MC, Francini F, Gagliardino JJ, Massa ML. Lipoic acid prevents fructoseinduced changes in liver carbohydrate metabolism: role of oxidative stress. Biochim Biophys Acta 2014;1840:1145-51
13. Petersen Shay K, Moreau RF, Smith EJ, et al. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 2009;1790:1149-60
14. Elliott JD, Steele J, Johnson WS. Assymetric synthesis via acetal templates.Highly diastereoselective coupling reactions with a ketene acetal. An efficient, asymmetric synthesis of R-(+)-alpha-lipoic acid. Tetrahedron Lett 1985;26:2535-8
15. Page PCB, Rayner CM, Sutherland IO. Enantioselective synthesis of R-(+)-aplha-lipoic acid. J Chem Soc. Chem Commun 1986;18:1408-9
16. Zimmer R, Hain U, Berndt M, et al. Enantioselective synthesis of (S)-and (R)-6-hydroxy-8-nonene-carboxylates by asymmetric catalysis: a formal synthesis of (R)-alpha-lipoic acid and its (S)-antipode. Tetrahedron Asymmetry 2000;11:879-87
17. Upadhya TT, Nikalje MD, Sudalai A. Assymetric dihydroxylation and hydrogenation approaches to the enantioselective synthesis of R-(+)-alpha-lipoic acid. Tetrahedron Lett 2001;42:4891-3
18. Chavan SP, Pravven C, Ramakrishna G, Kalkote UR. Enantioselective synthesis of R-(+)-alpha and S-(-)-alpha-lipoic acid. Tetrahedron Lett 2004;45:6027-8
19. Wei Z, Lan H-Q, Zheng J-F, Huang P-Q. New and concise approach to (R)-alpha-lipoic acid. Synth Commun 2009;39:691-701
20. Horikawa M, Kaku H, Nishii T, et al. Enantioselective total synthesis of (R)-alpha-Lipoic acid: An application of thermodynamically controlled deracemization of (±)-2-(2-Methoxyethyl) cyclohexanone. Synthesis 2010;17:2931-4
21. Koufaki M, Detsi A, Kiziridi C. Multifunctional lipoic acid conjugates. Curr Med Chem 2009;16:4728-42
22. Koufaki M, Detsi A. Design and synthesis of antioxidant alpha-lipoic acid hybrids. Methods Mol Biol 2010;594:297-309
23. Koufaki M, Calogeropoulou T, Detsi A, et al. Novel potent inhibitors of lipid peroxidation with protective effects against reperfusion arrhythmias. J Med Chem 2001;44:4300-3
24. Koufaki M, Detsi A, Theodorou E, et al. Synthesis of chroman analogues of lipoic acid and evaluation of their activity against reperfusion arrhythmias. Bioorg Med Chem 2004;12:4835-41
25. Vassilopoulos A, Papazafiri P. Attenuation of oxidative stress in HL-1 cardiomyocytes improves mitochondrial function and stabilizes Hif-1a. Free Radic Res 2005;39:1273-84
26. Kates SA, Casale RA, Baguisi A, Beeuwkes R III. Lipoic acid analogs with enhanced pharmacological activity. Bioorg Med Chem 2014;22:505-12
27. Guillonneau C, Charton Y, Ginot Y-M, et al. Synthesis and pharmacological evaluation of new 1,2-dithiolane based antioxidants. Eur J Med Chem 2003;38:1-11
28. Bolognesi ML, Minarini A, Tumiatti V, Melchiorre C. Lipoic acid, a lead structure for multi-target-directed drugs for neurodegeneration. Mini Rev Med Chem 2006;6:1269-74
29. Bolognesi ML, Cavalli A, Bergamini C, et al. Toward a rational design of multitarget-directed antioxidants: merging memoquin and lipoic acid molecular frameworks. J Med Chem 2009;52:7883-6
30. Decker M, Kraus B, Heilmann J. Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant properties. Bioorg Med Chem 2008;16:4252-61
31. Di Stefano A, Sozio P, Cocco A, et al. L-Dopa-and dopamine-(R)-alpha- lipoic acid conjugates as multifunctional codrugs with antioxidant properties. J Med Chem 2006;49:1486-93
32. Koufaki M, Kiziridi C, Nikoloudaki F, Alexis MN. Design and synthesis of 1,2-dithiolane derivatives and evaluation of their neuroprotective activity. Bioorg Med Chem Lett 2007;17:4223-7
33. Koufaki M, Kiziridi C, Alexi X, Alexis MN. Design and synthesis of novel neuroprotective 1,2-dithiolane/chroman hybrids. Bioorg Med Chem 2009;17:6432-41
34. Zara S, Rapino M, Sozio P, et al. Ibuprofen and lipoic acid codrug 1 control Alzheimer's disease progression by down-regulating protein kinase C "-mediated metalloproteinase 2 and 9 levels in beta-amyloid infused Alzheimer's disease rat model. Brain Res 2011;1412:79-87
35. Cacciatore I, Fornasari E, Baldassarre L, et al. A potent (R)-alpha-bis-lipoyl derivative containing 8-hydroxyquinoline scaffold: synthesis and biological evaluation of its neuroprotective capabilities in SH-SY5Y human neuroblastoma cells. Pharmaceuticals 2013;6:54-69
36. Zhang H, Ye N, Zhou S, et al. Identification of N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate as a new anti-Parkinson's agent possessing a dopamine D2 and serotonin 5-HT1A dual-agonist profile. J Med Chem 2011;54:4324-38
37. Prezzavento O, Arena E, Parenti C, et al. Design and synthesis of new bifunctional Sigma-1 selective ligands with antioxidant activity. J Med Chem 2013;56:2447-55
38. Connell J, Saleh MC, Kucukkaya I, et al. UPEI-300, a conjugate of lipoic acid and edaravone, mediates neuroprotection in ischemia/reperfusion. Neurosci Lett. 2014;561:151-5
39. Venkatraman MS, Chittiboyina A, Meingassner J, et al. Alpha-lipoic acidbased PPARg agonists for treating inflammatory skin diseases. Arch Dermatol Res 2004;296:97-104
40. Detsi A, Bouloumbasi D, Prousis KC, et al. Design and synthesis of novel quinolinone-3-aminoamides and their alpha-lipoic acid adducts as antioxidant and anti-inflammatory agents. J Med Chem 2007;50:2450-8
41. Melagraki G, Afantitis A, Igglessi-Markopoulou O, et al. Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts. Eur J Med Chem 2009;44:3020-6
42. Kodela R, Chattopadhyay M, Kashfi K. NOSH-aspirin: a novel nitric oxidehydrogen sulfide-releasing hybrid: A new class of anti-inflammatory pharmaceuticals. ACS Med Chem Lett 2012;3:257-62
43. Gruzman A, Hidmi A, Katzhendler J, et al. Synthesis and characterization of new and potent a-lipoic acid derivatives. Bioorg Med Chem 2004;12:1183-90
44. Chittiboyina A, Venkatraman MS, Mizuno CS, et al. Design and synthesis of the first generation of dithiolane thiazolidinedione-and phenylacetic acidbased PPARgamma agonists. J Med Chem 2006;49:4072-84
45. Antonello A, Hrelia P, Leonardi A, et al. Design, synthesis and biological evaluation of prazosin-related derivatives as multipotent compounds. J Med Chem 2005;48:28-31
46. Antonello A, Tarozzi A, Morroni F, et al. Multitarget-directed drug design strategy: a novel molecule designed to block Epidermal Growth Factor Receptor (EGFR) and to exert proapoptotic effects. J Med Chem 2006;49:6642-5
47. Kaskiw MJ, Tassotto ML, Th'ng J, Jiang Z-H. Synthesis and cytotoxic activity of diosgenyl saponin analogues. Bioorg Med Chem 2008;16:3209-17
48. Zhang S-J, Ge Q-F, Guo D-W, et al. Synthesis and anticancer evaluation of a-lipoic acid derivatives. Bioorg Med Chem Lett 2010;20:3078-83
49. Bernini R, Crisante F, Merendino N, et al. Synthesis of a novel ester of hydroxytyrosol and a-lipoic acid exhibiting an antiproliferative effect on human colon cancer HT-29 cells. Eur J Med Chem 2011;46:439-46
50. Lu C, Kim B-M, Chai KY. Design, synthesis and evaluation of PEGylated lipoic acid derivatives with functionality as potent anti-melanogenic agents. Eur J Med Chem 2011;46:5184-8
51. Tsuji-Naito K, Hatani T, Okada T, Tehara T. Modulating effects of a novel skin-lightening agent, alpha-lipoic acid derivative, on melanin production by the formation of DOPA conjugate products. Bioorg Med Chem 2007;15:1967-75
52. Picotti F, Fabbian M, Gianni R, et al. Hyaluronic acid lipoate: synthesis and physicochemical properties. Carbohydr Polym 2013;93:273-8
53. Gelo-Pujic M, Desmurs J-R, Delaire S, et al. Synthesis of new antioxidant conjugates and their in vitro hydrolysis with Stratum corneum enzymes. Int J Cosmet Sci 2008;30:195-204
54. MartíA, Costero AM, Gavina P, et al. Functionalized gold nanoparticles as an approach to the direct colorimetric detection of DCNP nerve agent simulant. Eur J Org Chem 2013;2013(22):4770-9
55. Kitamura N, Tanaka K, Chujo Y. Heat-initiated detection for reduced glutathione with 19F NMR probes based on modified gold nanoparticles Bioorg. Med Chem Lett 2013;23:281-6
56. Labib M, Martic S, Shipman PO, Kraatz HB. Electrochemical analysis of HIV-1 reverse transcriptase serum level: exploiting protein binding to a functionalized nanostructured surface. Talanta 2011;85:770-8
57. Montero JL, Saada MC, Winum JY, et al. Carbonic anhydrase activators: gold nanoparticles coated with derivatized histamine, histidine, and carnosine show enhanced activatory effects on several mammalian isoforms. J Med Chem 2011;54:1170-7
58. Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2004;21:114-21
59. Singh U, Jialal I. Alpha-lipoic acid supplementation and diabetes. Nutrition Rev 2008;66:646-57
60. Vallianou N, Evangelopoulos A, Koutalas P. Alpha-lipoic acid and diabetic neuropathy. Rev Diabet Stud 2009;6:230-6
61. Golbidi S, Badran M, Laher I. Diabetes and alpha lipoic acid. Front Pharmacol 2011;2:69
62. Kisanuki A, Kimpara Y, Oikado Y, et al. Ring-Opening Polymerization of Lipoic Acid and Characterization of the Polymer. J Polym Sci A Polym Chem 2010;48:5247-53
63. K-Pax Pharmaceuticals, Inc. Compositions and methods for treatment Therapeutic applications of lipoic acid of chronic fatigue. WO2012178014; 2012
64. Cuomo J, Brown MJ, Dixon BM, Schneider E. Nutritional supplements containing lipoic acids and sulfur containing compounds. US20130034632; 2013
65. Cuomo J, Brown MJ, Dixon BM, Dern A. Methods for using nutritional supplements containing lipoic acids and sulfur containing compounds. US20130045273; 2013
66. Kaiser JD. Nutrient compositions and methods for enhanced effectiveness of the immune system. US20130183277; 2013
67. Giellepi SP. A Composition comprising alpha-lipoic acid and honokiol for treating neuropathies. WO2013156971; 2013
68. CBB Net S.A. Process for the preparation of (R) alpha-lipoic acid salts, their formulation and use in pharmaceutical compositions, in form of tablets containing them. EP2386552; 2011
69. Celltrion Chemical Research Institute, Celltrion Pharm, Inc. Pharmaceutical composition comprising piperazine dithioctate and glimepiride. WO2011152658; 2011
70. Istituto Biochimico Nazionale Savio S.R. L. Basic alpha-lipoic acid solution and its uses. WO2013018008; 2012
71. Unilever Plc, Unilever N.V, Hindustan Unilever Ltd. Edible composition. WO2013007447; 2012
72. Bilgic M. Synergistic combination comprising a meglitinide derivative and lipoic acid. WO2013115740; 2013
73. Nutramax Laboratories, Inc. Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration. WO2012162063; 2012
74. Palepu NR. Docetaxel formulations with lipoic acid. US20120129922; 2011
75. Baylor College Of Medicine. Lipoic acid compositions useful as antimicrobial agents. WO2013181529; 2013
76. Milne JC, Jirousek MR, Bemis JE, Vu CB. Lipoic acid acylated salicylate derivates and their uses. US20110082192; 2010
77. Radikal Therapeutics, Inc. Lipoic acid and nitroxide derivatives and uses thereof. WO2011141909; 2011
78. Kandula M. Compound and method for the treatment of pain. US20110237658; 2011
79. Kandula M. 2,6-xylidine derivatives for the treatment of pain. US20120022147; 2011
80. Kandula M. Compositions and methods for the treatment of chronic pain. WO2013168011; 2013
81. Nativi C, Ghelardini C, La MG, Dragoni E. Compounds with both analgesic and anti-hyperalgesic efficacy. WO2011080725; 2011
82. Dutta P. Diacylglycerol based alphalipoic acid derivatives as antioxidants and agents for blocking food intake. WO2011078785; 2010
83. Jinan University. Danshensu and Chuanxiongqin derivatives, process for preparation and use thereof. WO2012103813; 2012
84. Ischemix Llc. Lipoyl compounds and their use for treating ischemic injury. WO2012067947; 2011
85. Cedars-Sinai Medical Center. Antioxidant, neuroprotective and antineoplastic nanoparticles comprising a therapeutic agent on an amphiphilic spacer or amphiphilic polymer. WO2013016696; 2012
86. Jiangsu Inst. of education. Lipoic acid saccharide derivatives as well as preparation method and application thereof in preparation of anti-tumor drugs. CN103360437; 2013
87. Taizhou Vocational & Technical College. Novel lipoic octanoylhydrazide derivative, preparation method and application thereof. CN102757425; 2012
88. University Of Prince Edward Island. Apocynin-Lipoic acid conjugates and uses thereof. WO2013071400; 2012
89. Univ. Hefei Technology. Ginkgolide B derivative based on double target spots of PAF (Platelet Activating Factor)/ROS (Reactive Oxygen Species), and preparation method of derivative. CN103242337; 2013
90. Kandula M. Compositions and methods for treatment of Parkinson's disease. WO2013168023; 2013
91. Laszlo JA, Compton DL, Evans KO. Vegetable oil esterified lipoic acid. US8455666 B1; 2013
92. Dobson PD, Kell DB. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nat Rev. Drug Discovery 2008;7:205-20
93. Vadlapudi AD, Vadlapatla RK, Mitra AK. Sodium dependent multivitamin transporter (SMVT): a potential target for drug delivery. Curr Drug Targets 2012;13:994-1003
94. Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 1999;22:1296-301
95. Sola S, Mir MQ, Cheema FA, et al. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation 2005;111:343-8
96. Ziegler D, Ametov A, Barinov A, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006;29:2365-70
97. Koh EH, Lee WJ, Lee SA. Effects of alpha-lipoic acid on body weight in obese subjects. Am J Med 2011;124:851-8
98. Ziegler D, Low PA, Litchy WJ, et al. Efficacy and safety of antioxidant treatment with a-lipoic acid over 4 years in diabetic polyneuropathy the NATHAN 1 trial. Diabetes Care 2011;34:2054-60
99. Georgakouli K, Deli CK, Zalavras A, et al. a-Lipoic acid supplementation up-regulates antioxidant capacity in adults with G6PD deficiency. Food Chem Toxicol 2013;61:69-73
100. Fogarty MC, Devito G, Hughes CM. Effects of a-lipoic acid on mtdna damage after isolated muscle contractions. Med Sci Sports Exerc 2013;45:1469-77
101. Rosini M, Andrisano V, Bartolini M, Melchiorre C. Organic compounds useful for the treatment of Alzheimer's Disease, Their use and method of preparation. WO2006080043; 2005
102. Nativi C, Gualdani R, Dragoni E, et al. A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain. Sci Rep 2003;3:2005